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ABSTRACT
Objectives: The aim was to assess the perceived
needs of medicines information and information
sources for pregnant women in various countries.
Design: Cross-sectional internet-based study.
Setting: Multinational.
Participants: Pregnant women and women with
children less than 25 weeks.
Primary and secondary outcome measures: The
need for information about medicines was assessed by
a question: ‘Did you need information about medicines
during the course of your pregnancy?’ A list of
commonly used sources of information was given to
explore those that are used.
Results: Altogether, 7092 eligible women responded
to the survey (5090 pregnant women and 2002 women
with a child less than 25 weeks). Of the respondents,
57% (n=4054, range between different countries
46–77%) indicated a need for information about
medicines during their pregnancy. On average,
respondents used three different information sources.
The most commonly used information sources were
healthcare professionals—physicians (73%), pharmacy
personnel (46%) and midwifes or nurses (33%)—and
the internet (60%). There were distinct differences in
the information needs and information sources used in
different countries.
Conclusions: A large proportion of pregnant women
have perceived information needs about medicines
during pregnancy, and they rely on healthcare
professionals. The internet is also a widely used
information source. Further studies are needed to
evaluate the use of the internet as a medicines
information source by pregnant women.
INTRODUCTION
Medicine use during pregnancy is
common.1 2 Most pregnant women use at
least one medication during pregnancy.3 4
There is also evidence of an increase in the
use of medicines during pregnancy, from an
average number of 2.5 in 1976–1978 to 4.2 in
2006–2008 in the USA.4 Pregnant women’s
beliefs and risk perceptions inﬂuence their
decisions on whether or not to use a medica-
tion during pregnancy.5 The availability and
use of reliable information sources are there-
fore important to ensure safe and rational
use of medicines during pregnancy. The
increasing use of the internet and social
media as a source of information and social
support is challenging for the healthcare
sector in trying to maximise its beneﬁts and
minimise its risks.
Health information needs and internet use
of pregnant women have been studied more
widely6–9 than the information needs con-
cerning medicines in speciﬁc. Questions
related to medicine use are among the four
most important questions pregnant women
have.10 Earlier studies have shown that some
40–80% of pregnant women have perceived
information needs about medicine use
during their pregnancy.2 11 12 The most
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▪ The internet is a widely used information source
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commonly used source of information has been physi-
cians/prenatal care providers,2 11–13 followed by pharma-
cists and family members.2 12 The use of books and
magazines has also been reported.12 13 However, with
growing access to the internet and social media, the role
of healthcare personnel is bound to change from the
keeper of information to the provider of coaching and
assessing information including second opinions. It is
also expected that women will use several different
sources to compare the information content.
This study was the ﬁrst to compare pregnant women’s
needs for information and sources about medicines in
different countries. We hypothesise that the overall need
for information about medications during pregnancy is
widespread across different countries. Thus, our aim was
to assess the perceived need for medicines information
during pregnancy and which information sources are
used in different regions of the world.
MATERIAL AND METHODS
Study design and population
This study is part of a multinational collaborative study
about Medication Use in Pregnancy. Member countries
of Teratology Information Service network, that is,
ENTIS in Europe, OTIS in North and South America
and Mothersafe in Australia, were invited to take part in
the project. Of these, the following countries/regions
agreed to take part in the project and conduct the
study: Norway, Sweden, Finland, Iceland, Italy, France,
the UK, Austria, Switzerland, the Netherlands, Poland,
Slovenia, Croatia, Serbia, Russia, the USA, Canada,
Australia and South America (table 1).
An anonymous self-completed internet-based ques-
tionnaire administered by the Questback programme
(http://www.questback.com/) was used. Invitations to
the study were posted on 1–4 internet websites used by
pregnant women in regions around the world. Before
being given access to the online questionnaire, each
study participant had to read the study description in
which the study objectives, participants’ right to with-
draw from the study at any time and contact persons in
the applicable country were presented. Each participant
was then asked whether she was willing to participate in
the study and ﬁll out the online questionnaire. Only
after clicking ‘yes’ was the participant redirected to the
webpage on which the full online questionnaire could
be ﬁlled in. Reading the study description and complet-
ing the questionnaire were considered to be giving
informed consent.
The questionnaire was accessible during a period of
2 months in each country. All the data were collected
during the period of 1 October 2011 to 29 February
2012. Pregnant women and breastfeeding women with a
child less than 1-year old were eligible to participate in
the study; however, in this substudy, only pregnant
women and breastfeeding women with a child less than
6 months (less than 25 weeks) were eligible. The women
were advised to answer the questions related to their
current or latest pregnancy.
The number of women who accessed the on-line ques-
tionnaire in the various countries was 9615. Of these
women, 9483 (98.6%) accepted the participation in the
study and ﬁlled in the questionnaire. Of these responses,
5090 were from pregnant women and 2002 from women
with a child less than 25 weeks old. Thus, the ﬁnal study
population was 7092 (ﬁgure 1). The study population in
each country was compared with the birthing population
using national or population-based statistics (see online
supplementary ﬁle 1).
The ethics approval for the study was obtained from
the Norwegian Regional Ethics Committee. All data
were handled and stored anonymously.
Questionnaire
The internet questionnaire, originally developed by
researchers at the University of Oslo (AL and HN), was
ﬁrst translated into English and then into the respective
languages of the participating countries. The study ques-
tions largely followed the ones used in the study by
Nordeng et al.2 5 The questionnaire was piloted in four
countries (Norway, Sweden, Finland and Italy) and only
minor changes were made. The pilot responses were not
included in the study dataset.
The questionnaire included the following sections:
background information about the pregnant woman
and her pregnancy; health disorders and use of medi-
cines during pregnancy; needs for information; medi-
cines for chronic diseases during pregnancy; attitudes
towards using medicines in general and during the preg-
nancy; and perceptions of risks during pregnancy.
Standardised questions about maternal factors were
posed to the subjects, with emphasis on the presence of
acute and long-term illnesses during pregnancy. In
afﬁrmative case, women were questioned about the use
of medicines for each individual illness as free-text entry.
This study analyses and reports on the data about the
information needs.
Main outcome measures
Women were asked about their needs for information
regarding the use of medicines during pregnancy and
the sources of information they had used. The need for
information was assessed by a question: ‘Did you need
information about medicines during the course of your
pregnancy?’ A list of commonly used sources of informa-
tion was also given to explore the information sources
used, and the respondent had a chance to mention
other sources used (table 2).
Statistical analysis
The Statistical Package for Social Sciences, V.20 (SPSS
Inc, Chicago, Illinois, USA) was used to analyse the data.
Descriptive statistics were used to calculate the results,
that is, frequencies, percentages and cross-tabulation.
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RESULTS
Study population
The average age of the respondents was 29 years (inter-
percentile range 23–36; table 1). Of the respondents,
53% were primiparous, and 55% had a university or
college degree. Overall, the mean age of our study
populations is quite close to that of the target popula-
tions in each participating country (table 1). The per-
centage of primiparity was somewhat higher among our
study participants than among most national popula-
tions. Likewise, our participants had a somewhat higher
education when measured by the percentage of univer-
sity or college graduates.
Information needs
Of the respondents, 57% (n=4054) stated having
needed information about medicines during their preg-
nancy (ﬁgure 2). Respondents from Eastern Europe
needed information the most (72%). The respondents
in other regions of the world needed it less: Northern
Europe 57%, Australia 56%, Western Europe 51% and
North and South America 50%. The need for
information varied between countries from 46% (the
UK and Norway) to 77% (Finland).
Information sources
The most commonly used information sources were
healthcare professionals, especially physicians (73%),
pharmacy personnel (46%), midwifes or nurses (33%)
and the internet (60%; table 2). On average, the respon-
dents used three different information sources.
There were differences in the information sources
used in different countries. Midwives and nurses were
often asked for information in Northern Europe (50%),
but they were rarely contacted in Eastern Europe (14%).
On the other hand, the internet was most commonly
used in Eastern Europe (75%). Pregnant women in
Northern Europe (49%) used drug handbooks and
information leaﬂets more often than women in other
parts of the world. Drug information centres were com-
monly used in Australia (24%) and the USA (24%), but
they were very rarely used in Eastern Europe (1%).
Pregnant women in Eastern Europe (10%), especially in
Croatia (17%) and Russia (13%), reported using other
sources of information such as magazines, media, books
Table 1 Characteristics of the study population (n=7092), and comparative national population data (see online
supplementary file 1)
Age of
mother
National
data on
age
Mother
primiparous
National data
on primiparity
Education,
university/
college
National data
on education
n Mean (IPR*) Mean age Per cent Per cent Per cent Per cent
Total 7092 29 (23 to 36)† 53 55
Eastern Europe 1532 28 (22 to 34) 55 67
Russia 606 27 (21 to 34) 27 56 NA 72 NA
Croatia 174 30 (24 to 36) 28 59 47 62 44
Poland 500 27 (21 to 32) 29 55 50 63 42
Serbia 131 29 (25 to 34) 29 53 51 59 29
Slovenia 121 32 (26 to 37) 30 50 49 71 43
Northern Europe 2184 29 (23 to 35)‡ 52 54
Finland 483 29 (22 to 35) 30 42 42 54 48
Iceland 65 § NA 51 38 45 48
Sweden 703 30 (23 to 36) 30 64 45 62 51
Norway 933 29 (23 to 35) 30 49 42 48 55
Australia 175 31 (24 to 38) 31 49 44 62 56
Western Europe 2519 31 (25 to 37) 55 49
Austria 51 30 (23 to 36) 30 57 48 45 23
Italy 787 32 (26 to 38) 31 62 49 45 26
Switzerland 461 31 (26 to 37) 31 49 NA 45 39
France 319 30 (24 to 37) 30 54 44 58 47
The Netherlands 47 30 (23 to 36) 31 40 46 23 44
UK 854 30 (23 to 37) 30 54 42 53 46
Americas 682 28 (21 to 36) 46 52
The USA 231 29 (21 to 37) NA 46 40 65 58
Canada 186 28 (21 to 34) 30 52 43 68 70
South-American
Countries
265 27 (20 to 34) NA 42 NA 30 NA
*Interpercentile range (IPR) calculated 10th to 90th percentile.
†Calculated based on 7028 values, because 64 values from Iceland were not available.
‡Calculated based on 2120 values, because 64 values from Iceland were not available.
§Not shown because 64 values were not available.
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and complementary medicine personnel. On average,
one-fourth of the respondents discussed medicine use
with their family and friends.
DISCUSSION
This is the ﬁrst study to assess women’s needs for medi-
cine information during pregnancy on a multinational
level. Over half of the pregnant women who responded
to the internet survey in different countries indicated a
need for information related to medicine use during
pregnancy. Pregnant women used multiple information
sources, however, healthcare professionals, especially
physicians, being the most common. The internet was
also a widely used information source for pregnant
women. There were distinct differences in the perceived
needs for information and sources of information used
in different countries.
The fact that most of the pregnant women in this as
well as previous studies report using healthcare profes-
sionals as a source is reassuring.2 11 12 Physicians are the
key persons when counselling pregnant women on
medicine use. However, our results show that the inter-
net is also commonly used today in different regions of
the world (ranging from 45% to 90%) by pregnant
women. This is consistent with some previous
studies.2 7 9 12 The differences in information sources
used between different countries most probably reﬂect
different situations in terms of antenatal care as well as
available information sources in the countries. For
example, in Eastern Europe, where women did not
Figure 1 Formation of final study population.
Table 2 Medicines information sources used by pregnant women (n=4054)
Physician,
gynaecologist,
specialist (%)
Internet
(%)
Pharmacy
personnel
(%)
Drug
handbook,
Information
leaflet (%)
Midwife,
nurse
(%)
Family,
friends
(%)
Drug
information
centre (%)*
Other
(%)†
Total (n=4054) 73 60 46 35 33 24 7 7
Eastern Europe (n=1095) 77 75 46 32 14 29 1 10
Russia (n=456) 70 90 35 26 12 33 0 13
Croatia (n=130) 71 78 54 38 3 26 0 17
Poland (n=344) 89 54 52 34 23 30 3 6
Serbia (n=88) 88 81 63 38 5 24 0 6
Slovenia (n=77) 68 64 55 47 12 12 1 5
Northern Europe (n=1250) 66 54 47 49 50 23 6 3
Finland (n=372) 67 59 57 50 54 20 19 2
Iceland (n=44) 64 46 46 41 59 23 0 0
Sweden (n=408) 57 56 49 61 65 23 1 3
Norway (n=426) 74 49 37 37 32 25 1 5
Australia (n=98) 74 54 54 28 49 21 24 5
Western Europe (n=1273) 75 52 47 28 33 21 9 7
Austria (n=32) 88 72 75 63 16 16 3 9
Italy (n=419) 89 52 42 33 15 15 10 7
Switzerland (n=245) 84 53 54 38 13 15 5 7
France (n=159) 77 45 63 11 29 23 5 6
The Netherlands (n=23) 83 70 35 61 39 4 0 4
The UK (n=395) 52 51 42 18 68 31 13 7
Americas (n=338) 80 62 37 21 21 31 16 8
The USA (n=124) 81 74 35 29 27 30 24 7
Canada (n=96) 77 44 58 16 27 33 22 7
South-American
Countries (n=118)
82 63 23 16 9 31 3 9
*Poison information centres, teratology information services and national centres of information on medicines.
†Herbal shop personnel, complementary medicine personnel, magazines, media and books.
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often use midwives or nurses as information sources, the
use of the internet was most common. On the other
hand, in Australia the use of drug information centres
was high, most probably because of the availability of
such centres. The prevalent use of the internet is chal-
lenging for healthcare professionals. Increased aware-
ness and readiness to accept this is necessary to ensure a
rational approach towards the use of the internet in
health contexts.
Our ﬁndings may reﬂect that pregnancy is a special
time when the need for information is great, but the
ﬁndings could also be a more general cohort effect
reﬂecting the generations of young women today. The
societal change in the information society is concretised
by Palfrey and Gasser’s14 deﬁnitions of ‘Digital Natives’
as those generations born after 1980 and ‘Digital
Immigrants’ as those born before 1980. Thus, the new
generations internalise new forms of information and
communications technologies from childhood in a way
that has not happened before. Information about medi-
cines is readily available for everyone and Digital Natives
ﬁnd it and use it particularly easily. In this study, the
average age of the respondents was 29 years, indicating
that most of them were Digital Natives, and thus natural
internet users.
The development of the information society and
eHealth initiatives is aimed at empowering the consumer
and client. This is also in line with current trends in
healthcare from paternalism towards concordance.15 16
At the same time, the role of healthcare professionals
should expand from a mere information provider to a
supporter of care of an empowered patient. Healthcare
professionals need to be ready to discuss any topics
raised on health and medicines information although
there are some reports indicating that pregnant women
are not very prone to discuss information retrieved from
internet with their midwife.7 9 Healthcare professionals
need to discuss with their clients about what information
sources they use, interpret health information and tailor
it to speciﬁc needs. Moreover, there is also a growing
need to assess the quality of information with clients. It
is important to promote the use of tools such as the
DARTS checklist17 for the assessment of the quality of
online medicines information.
eHealth functions are much broader than just medi-
cines information, as they include functions such as
health information networks, electronic health records,
health portals and all kinds of tools to assist prevention,
diagnosis, treatment, health monitoring and lifestyle
management. As such, this major change in the
Figure 2 Women’s perceived
need for information about
medicines during pregnancy.
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healthcare sector also changes the way the medicines
information is delivered to medicine users. In fact, there
is a need for being prepared to increase visibility and
participation of healthcare professionals on the internet
and social media to balance lay views on issues related to
health and medicines. In the European Union, an
eHealth action plan was adopted in 200418 aimed at
facilitating a more harmonious and complementary
European approach to eHealth. The action plan is cur-
rently being revised.19
One limitation of our study is the fact that the question-
naire was only available through internet websites used by
pregnant women. Using this kind of approach, a conven-
tional response rate cannot be calculated. However, epi-
demiological studies using web-based recruitment
methods have shown reasonable validity.20–22 Internet use
is relatively high among individuals aged 25–34 years in
Europe, ranging from 48% in Russia to 100% in
Iceland.23 The internet penetration rates in other parts
of the world vary, being highest in the USA, Australia,
and Canada (80–94%) and lowest in South America
(48%).24–27 Thus, the degree to which our ﬁndings can
be extrapolated to the target population is based on the
representativeness of the respondents to the general
birthing populations in each country. Overall, the age
structure of our study population match quite well with
the target population in each participating country.
However, as in most questionnaire-based studies, the par-
ticipating women had somewhat higher educational level
than the general birthing populations in each country. It
is commonly known that more resourceful individuals
tend to be more favourable to participate in
questionnaire-based studies.28 29 This is likely the case for
this study as well since the study population is better edu-
cated than the general birthing population. As women
with higher education tend to seek information and to a
larger degree use several sources,28 30 we might have over-
estimated the need for information about medicines
during pregnancy. Among our study population, we had
also somewhat more primiparous women indicating a
higher need for medicines information in this subgroup.
Finally, we do not know which internet websites the
respondents have used. Some of the information used
may be highly reliable and relevant, while others may be
unreliable or biased.
In conclusion, a large proportion of pregnant women
report the need for information about medicines during
pregnancy, and they rely on healthcare professionals.
The internet is also a widely used information source
across the countries in this study. Further studies are
needed in order to evaluate internet use as a medicines
information source by pregnant women.
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